$1.170
-0.039 (-3.31%)Al cierre
Noticias de BNGO
Eventos de BNGO
Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer
Bionano Genomics announced the appointment of Alex Hastie as its chief scientific officer, or CSO, effective July 20. In this role, Hastie will lead the company's global scientific strategy, innovation roadmap, and research initiatives, advancing Bionano's mission to expand the research application of its genome analysis technologies and to develop a clinical applications strategy.
Bionano Genomics Study Shows OGM Detects 97.8% of T-ALL Genetic Abnormalities
Bionano Genomics announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping, OGM, detected genomic abnormalities in 97.8% of T-cell acute lymphoblastic leukemia cases - nearly double the 55% detection rate achieved by conventional cytogenetic analysis. Conducted by researchers at The University of Texas MD Anderson Cancer Center and Johns Hopkins University School of Medicine and representing one of the most comprehensive genomic analyses of T-ALL to date, the study underscores OGM's potential to transform how this aggressive blood cancer is studied and understood.
Bionano Genomics Files $400M Mixed Securities Shelf
Bionano Genomics files $400M mixed securities shelf
Bionano Genomics Appoints Al Luderer as Interim CEO
Bionano Genomics announced that Al Luderer, chairman of Bionano's board of directors, has been appointed interim president and chief executive officer, effective May 5. Luderer will continue to serve as chairman, and director Chris Twomey will serve as lead independent director. He succeeds Erik Holmlin who is staying on as an advisor.
Trump Postpones Strikes on Iranian Energy, Market Sentiment Improves
Hopes for de-escalation in the Middle East conflict helped restore positive sentiment as President Trump's Truth Social post that strikes on Iranian energy infrastructure would be postponed after "productive" talks with Tehran boosted equities and dented geopolitical premium in the energy markets. Consumer Discretionary and Materials were the best performing areas on the benchmark S&P 500, though all 11 sectors ended Monday in the positive - including Energy in spite of Oil prices falling back below $90 per barrel. In the opening hour of the evening session, S&P 500 futures are up another 0.2% and Nasdaq 100 is trading up 0.3% while WTI Crude is just off the closing lows above $89. In precious metals, risk aversion which had boosted USD and punished Gold and Silver prices has reversed, and the two contracts are trading firmer around $4.435 and $70 per ounce respectively.Among the key headlines of the afterhours session continued to remind investors that the primary source of concern are still present. Core Labsissued a below-consensus Q1 pre-announcement as the company cited regional instability in the Middle East, including client-driven project delays, travel constraints, and supply-chain disruptions. Private Credit worries also cropped up via reports from Bloomberg stating that Apollo Globalhas joined some of the other asset managers in capping private equity redemptions due to high volume of requests by investors to liquidate their positions.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -BARKup 6.4%Bionano Genomicsup 4.1%DOWN AFTER EARNINGS -Core Laboratoriesdown 1.8% after Q1 pre-announcementAardvark Therapeuticsdown 1.5%ALSO LOWER -Comtech Telecommunicationsdown 3.9% after equity offeringApollo Global Managementdown 2.1% after Bloomberg report of capped private equity redemptions
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.